ICARDI, GIANCARLO ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 37.213
AS - Asia 4.401
NA - Nord America 2.756
SA - Sud America 408
AF - Africa 69
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 44.857
Nazione #
IT - Italia 36.444
US - Stati Uniti d'America 2.612
SG - Singapore 1.843
CN - Cina 1.132
VN - Vietnam 813
FR - Francia 342
BR - Brasile 253
BD - Bangladesh 164
HK - Hong Kong 138
DE - Germania 89
FI - Finlandia 84
AR - Argentina 73
JP - Giappone 55
GB - Regno Unito 54
CA - Canada 51
MX - Messico 51
IN - India 38
IQ - Iraq 32
ID - Indonesia 31
NL - Olanda 29
CH - Svizzera 23
PK - Pakistan 23
RU - Federazione Russa 23
VE - Venezuela 20
EC - Ecuador 19
PH - Filippine 19
CO - Colombia 14
ES - Italia 13
IE - Irlanda 13
ZA - Sudafrica 13
PL - Polonia 12
TH - Thailandia 12
UA - Ucraina 12
SA - Arabia Saudita 11
TN - Tunisia 11
RO - Romania 10
UZ - Uzbekistan 10
EG - Egitto 9
PY - Paraguay 9
TR - Turchia 9
AT - Austria 8
CR - Costa Rica 8
JO - Giordania 8
KE - Kenya 8
AU - Australia 7
KR - Corea 7
MY - Malesia 7
JM - Giamaica 6
MA - Marocco 6
PE - Perù 6
AL - Albania 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
LT - Lituania 5
PA - Panama 5
SV - El Salvador 5
TW - Taiwan 5
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
CL - Cile 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
NP - Nepal 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
LU - Lussemburgo 3
OM - Oman 3
PS - Palestinian Territory 3
BE - Belgio 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
IS - Islanda 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
Totale 44.832
Città #
Genova 18.915
Genoa 10.654
Rapallo 3.555
Vado Ligure 2.700
San Jose 929
Singapore 887
Lauterbourg 313
Bordighera 300
Ashburn 278
Ho Chi Minh City 249
Beijing 201
Hanoi 180
Council Bluffs 146
New York 145
Hong Kong 131
Santa Clara 95
Helsinki 82
Frankfurt am Main 64
Los Angeles 50
Tokyo 49
Da Nang 37
Haiphong 35
Milan 35
Orem 33
Tianjin 29
Mexico City 28
Dallas 26
São Paulo 23
Buffalo 20
Rome 19
Zurich 19
Boardman 18
Hải Dương 18
Atlanta 17
Biên Hòa 17
Amsterdam 16
San Francisco 16
Chicago 14
City of London 14
Phoenix 14
Baghdad 13
London 13
Dublin 12
Charlotte 11
St Louis 11
Toronto 11
Houston 10
Lahore 10
Prato 10
Can Tho 9
Denver 9
Montreal 9
Amman 8
Bari 8
Bologna 8
Cardiff 8
Chennai 8
Guangzhou 8
Kyiv 8
Las Vegas 8
Marseille 8
Paris 8
Tashkent 8
Turin 8
Brasília 7
Buenos Aires 7
Dhaka 7
Memphis 7
Quito 7
Salt Lake City 7
San José 7
Thái Bình 7
Warsaw 7
Asunción 6
Curitiba 6
Jakarta 6
Nairobi 6
Nha Trang 6
Ninh Bình 6
Pasadena 6
Phủ Lý 6
Piscataway 6
Quảng Ngãi 6
Quận Ba 6
Quận Bình Thạnh 6
Shenzhen 6
Surabaya 6
Thái Nguyên 6
Verona 6
Belo Horizonte 5
Brooklyn 5
Columbus 5
Des Moines 5
Erbil 5
Guayaquil 5
Hangzhou 5
Jeddah 5
Johannesburg 5
Karbala 5
Maracaibo 5
Totale 40.809
Nome #
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection 494
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 259
Assessing Ebola-related web search behaviour: Insights and implications from an analytical study of Google Trends-based query volumes 249
Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. 230
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 221
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 220
Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. 218
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. 216
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis 215
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 215
Correct Identification of Dual HCV Infections in HIV/HCV CoInfected Patients 213
Assessment of knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy 213
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 208
La vaccinazione nel paziente con infezione da HIV: attuali raccomandazioni e strategie multidisciplinari per il raggiungimento dei soggetti suscettibili. L’esperienza della Liguria 208
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C 204
Ras-induced resistance to lapatinib is overcome by MEK inhibition 200
Vaccine-preventable infections in Systemic Lupus Erythematosus 200
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 196
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 194
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 193
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 190
Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives 188
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis 184
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine 182
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 182
Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients 180
RN4CAST@IT-Ped: Nurse staffing and children's safety 180
RN4CAST@IT: why is it important for Italy to take part in the RN4CAST project? 179
An unexpected Streptococcus pneumoniae strain. 178
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 177
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis 176
A comparison of hepatitis B seroepidemiology in ten European countries. 175
Bloodstream infections in critically ill patients with COVID-19 175
HCV-related polyradiculoneuropathy in a HIV-positive man 174
An eHealth project on invasive pneumococcal disease: Comprehensive evaluation of a promotional campaign 174
Current recommendation to reduce the burden of bacterial and viral infections in patients affected by systemic lupus erythematosus 172
Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy 172
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 170
[Novel approaches for the prevention of influenza: the intradermal vaccination. 170
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 170
Overview of hepatitis B virus mutations and their implications in the management of infection 170
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months 169
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 169
A bivalent meningococcal B vaccine in adolescents and young adults 168
Different evidence of key amprenavir resistance mutations on the efficacy of darunavir 167
Factors predicting influenza vaccination adherence among patients in dialysis: an Italian survey 167
Universal influenza virus vaccines: what needs to happen next? 166
Reactivation of Hepatitis B virus infection during cytotoxic chemotherapy 165
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months 165
Clinical and economic impact of herpes zoster vaccination in elderly in Italy 165
Burden and prevention of hpv. Knowledge, practices and attitude assessment among pre-adolescents and their parents in Italy 165
Analytical and laboratory evaluation of a new fully-automated third generation enzyme immunoassay for the detection of antibodies to the hepatitis C virus 163
Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy. 163
Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine. 163
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 162
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis 162
Monitoraggio della gestione pre ed intra-operatoria del paziente sottoposto ad intervento chirurgico presso l’A.O.U. San Martino di Genova 161
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization 160
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 159
Evaluation of performance of RIBA processor system for automated analysis of the strip immunoblot assay for detection of antibodies to hepatitis C virus 159
Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses. 159
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 159
Prevalence and predictors of latent tuberculosis infection among Italian State Policemen engaged in assistance to migrants: A national cross-sectional study 159
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 158
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 158
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy 157
Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience 157
An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission 156
A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals 156
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 156
Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study 155
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. 155
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 154
BT3 molecules ligation enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 153
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 153
Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response 152
An outbreak of influenza in a residential drug-rehabilitation community 151
Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. 151
Fluzone® intra-dermal (Intanza® / Istivac® Intra-dermal): An updated overview 151
A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients 151
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement 149
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 149
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 149
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 149
MOLECULAR AND SEROLOGICAL DIVERSITY OF NEISSERIA MENINGITIDIS CARRIER STRAINS ISOLATED FROM ITALIAN STUDENTS AGED 14-22 YEARS. 148
Vaccinazione antinfluenzale degli operatori sanitari presso l’IRCCS AOU San Martino-IST di Genova: progetto-pilota di counselling e offerta attiva direttamente presso reparti a elevato rischio 148
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 148
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. 148
Characterization of hepatitis C virus genotypes in Italian subjects at different risk of infection. 147
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 147
European Academy of Nursing Science 2016 Summer Conference 147
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 146
Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project) 145
Efficacy and safety of darunavir and etravirine in an antiretroviral multiexperienced youth with vertically HIV-1 infection 145
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. 144
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains 144
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 144
Totale 17.503
Categoria #
all - tutte 152.482
article - articoli 136.735
book - libri 253
conference - conferenze 9.329
curatela - curatele 0
other - altro 0
patent - brevetti 1.068
selected - selezionate 0
volume - volumi 5.097
Totale 304.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 0 0 200
2021/20223.775 80 228 278 459 150 236 200 929 225 346 125 519
2022/20234.263 404 340 58 398 616 802 34 330 677 80 471 53
2023/20242.447 123 320 45 274 194 316 106 411 149 55 162 292
2024/20257.005 262 485 194 524 841 683 719 1.104 239 375 745 834
2025/202612.374 1.485 341 1.088 992 1.515 1.079 1.962 632 980 1.172 715 413
Totale 45.371